tiprankstipranks
Mochida Pharmaceutical Co., Ltd. (DE:MFY)
FRANKFURT:MFY
Germany Market

Mochida Pharmaceutical Co., Ltd. (MFY) Income Statement

Compare
0 Followers

Mochida Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q1 2024), Mochida Pharmaceutical Co., Ltd.'s total revenue was ¥25.41B, an increase of 2.67% from the same quarter last year. In Q1, Mochida Pharmaceutical Co., Ltd.'s net income was ¥1.55B. See Mochida Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 102.89B¥ 103.26B¥ 110.18B¥ 103.00B¥ 101.80B
Gross Profit
¥ 52.07B¥ 55.12B¥ 59.55B¥ 54.79B¥ 51.92B
Operating Expenses
¥ 46.27B¥ 46.61B¥ 45.16B¥ 42.79B¥ 43.11B
Depreciation and Amortization
¥ 2.81B¥ 2.67B¥ 2.69B¥ 2.74B¥ 2.73B
EBITDA
¥ 8.97B¥ 11.71B¥ 17.28B¥ 14.75B¥ 11.54B
Operating Income
¥ 5.80B¥ 8.51B¥ 14.39B¥ 12.00B¥ 8.81B
Other Income/Expenses
¥ 357.00M¥ 537.00M¥ 199.00M¥ -103.00M¥ -2.53B
Pretax Income
¥ 6.16B¥ 9.04B¥ 14.59B¥ 11.90B¥ 6.27B
Net Income
¥ 4.55B¥ 6.65B¥ 10.57B¥ 8.59B¥ 4.60B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 126.79¥ 178.93¥ 277.39¥ 222.27¥ 117.55
Diluted EPS
¥ 126.79¥ 178.93¥ 277.39¥ 222.27¥ 117.55
Weighted Average Shares Outstanding
35.86M 37.16M 38.10M 38.63M 39.12M
Weighted Average Shares Outstanding (Diluted)
35.86M 37.16M 38.10M 38.63M 39.12M
Currency in JPY

Mochida Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis